Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | KCNN4 | O15554 | 7/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.45 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Atrolactamide SCHEMBL28842804 | 0.92 | MAPT (0.57) | MAPTKMT2ACYP1A2CYP2D6KCNN4 | |
| Atrolactamide SCHEMBL28201551 | 0.90 | MAPT (0.55) | MAPTKMT2ACYP1A2CYP2D6KCNN4 | |
| Atrolactamide SCHEMBL28875745 | 0.86 | CA2 (0.52) | MAPTKMT2ACYP1A2CYP2D6KCNN4 | |
| Atrolactamide SCHEMBL28540119 | 0.84 | MAPT (0.49) | MAPTKMT2ACYP1A2CYP2D6ALDH1A1 | |
| Atrolactamide SCHEMBL31758013 | 0.84 | LMNA (0.58) | MAPTKMT2ACYP1A2CYP2D6LMNA | |
| Atrolactamide SCHEMBL6903234 | 0.84 | MAPT (0.49) | MAPTKMT2ACYP1A2CYP2D6KCNN4 | |
| SCHEMBL197251 | 0.81 | MAPT (0.52) | MAPTKMT2ACYP1A2CYP2D6KCNN4 | |
| SCHEMBL21557850 | 0.81 | MAPT (0.52) | MAPTKMT2ACYP1A2CYP2D6KCNN4 | |
| SCHEMBL198241 | 0.81 | MAPT (0.52) | MAPTKMT2ACYP1A2CYP2D6KCNN4 | |
| SCHEMBL4326795 | 0.81 | MAPT (0.52) | MAPTKMT2ACYP1A2CYP2D6KCNN4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1457 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120154546-A | Preparation method of osmotic absorption mask | 臧伟仲 | 2025-06-17 | — | — | CN | claimed |
| CN-119744164-A | Odor and colorant stable compositions | 西姆莱斯股份公司 | 2025-04-01 | — | — | CN | claimed |
| CN-119700634-A | Anti-aging composition containing sheep placenta extract, application thereof and cosmetics | 广州美姿生物科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119454557-A | Repairing and soothing liposome composition and preparation method and application thereof | 广东科盈科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119390602-A | Synthesis process of hydroxyphenyl propionamide benzoic acid | 青岛三人行化学有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-119345057-A | A polypeptide containing polydeoxyribonucleotide and its preparing process sodium hyaluronate composition and application thereof | 恒昱生物制药(山东)有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-119326695-A | Composition capable of relieving chronic itch of skin, preparation method and application | 春羽生物科技(无锡)有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-119185104-A | Soothing composition, application and cosmetic | 广州思瑞生物科技有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-119157807-A | Hair care composition and preparation method thereof | 广州科玛生物科技股份有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-119112688-A | Whitening and freckle-removing facial cream and preparation method thereof | 广东格烯生物科技股份有限公司 | 2024-12-13 | — | — | CN | claimed |
| WO-2005108393-A1 | PYRROLE OR IMIDAZOLE AMIDES FOR TREATING OBESITY | F. HOFFMANN-LA ROCHE AG (CH) | 2005-11-17 | — | — | WO | claimed |
| US-20050250769-A1 | Heterocyclic cannabinoid receptor antagonists | F. HOFFMANN-LA ROCHE AG (CH) | 2005-11-10 | — | — | US | claimed |
| WO-2004089364-A1 | AZABICYCLO DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES LIMITED (IN) | 2004-10-21 | — | — | WO | claimed |
| EP-1363906-A2 | HETEROCYCLIC INHIBITORS OF ERK2 AND USES THEREOF | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2003-11-26 | — | — | EP | claimed |
| WO-2002064586-A2 | HETEROCYCLIC INHIBITORS OF ERK2 AND USES THEREOF | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2002-08-22 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0537259-A1 | PROCESS FOR PRODUCING ENANTIOMERS OF 2-ARYL-ALKANOIC ACIDS | NOVO NORDISK A/S (DK) | 1993-04-21 | — | — | EP | claimed |
| WO-1992001062-A1 | PROCESS FOR PRODUCING ENANTIOMERS OF 2-ARYL-ALKANOIC ACIDS | NOVO NORDISK A/S (DK) | 1992-01-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050250769-A1 | Heterocyclic cannabinoid receptor antagonists | CNR1, CNR2, GPR18 | MAPT 4118/4885KMT2A 3110/4885CYP1A2 430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.